Exploring FGF21's mechanism of acute insulin sensitization
Iowa Research Online (The University of Iowa) · 05.07.2023
DOI: 10.25820/etd.006887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iowa Research Online (The University of Iowa), erschienen am 05.07.2023. Verfasst von Sheps King-McAlpin.
Abstract (Originalsprache)
Fibroblast growth factor 21 (FGF21) in an endocrine hormone that regulates carbohydrate homeostasis and is also a potential drug target for treating diabetes and other metabolic diseases. Circulating FGF21 is derived primarily from the liver and signals through a receptor complex consisting of β-klotho (KLB) and FGFR1c on tissues including the central nervous system and adipose tissues to mediate its metabolic effects. Acute administration of FGF21 to rodents enhances insulin sensitivity through direct actions on brown adipose tissue (BAT). However, FGF21’s insulin-sensitizing effect is variable in adult humans as it depends on the FGF21 analog used. This inconsistency between rodents and humans could be because adult humans have less BAT than mice when normalized to total respective body weights. Since BAT and skeletal muscle are derived from the same progenitor cells, we wanted to know if skeletal muscle could serve as a target tissue for FGF21-mediated enhancement of insulin-stimulated glucose uptake in humans. To explore the mechanism for FGF21’s acute insulin-sensitizing effect while examining whether this effect could be applied to skeletal muscle, a tissue which lacks the obligate FGF21 coreceptor KLB, we generated a mouse model overexpressing KLB in skeletal muscle. FGF21 did not improve insulin sensitivity through KLB-expressing skeletal muscle. To investigate FGF21’s mechanism of improving insulin sensitivity through BAT, we employed a unique GLUT4 translocation reporter system that dynamically reports insulin sensitivity in real-time. Here we show that FGF21 enhances GLUT4 translocation in BAT and brown adipocytes. Furthermore, we used global phosphoproteomics to identify signaling intermediates that are phosphorylated by FGF21 in primary brown adipocytes. These studies provide unique insight into the insulin-sensitizing effects of FGF21 and highlights specific FGF21 signaling intermediates to be characterized in pursuit of a novel therapeutic strategy for diabetes.
Schlagwörter
Zitieren
APA
King-McAlpin, S. (2023). Exploring FGF21's mechanism of acute insulin sensitization. Iowa Research Online (The University of Iowa). https://doi.org/10.25820/etd.006887
Vancouver
King-McAlpin S. Exploring FGF21's mechanism of acute insulin sensitization. Iowa Research Online (The University of Iowa). 2023. doi:10.25820/etd.006887
BibTeX
@article{KingMcAlpin2023,
author = {King-McAlpin, Sheps},
title = {Exploring FGF21's mechanism of acute insulin sensitization},
journal = {Iowa Research Online (The University of Iowa)},
year = {2023},
doi = {10.25820/etd.006887}
}
EUVIMED